Boehringer Ingelheim
A pharmaceutical company. It sponsored the EMPEROR-Reduced and EMPEROR-Preserved trials of empagliflozin. The US FDA record for Jardiance names Boehringer Ingelheim as the sponsor of the application.
- Organization
- In this atlas
Overview
Technical summary
Research Organization Registry record 00q32j219 lists Boehringer Ingelheim (Germany), a company and funder, in Ingelheim. EMPEROR-Reduced (NCT03057977) and EMPEROR-Preserved (NCT03057951) name Boehringer Ingelheim as lead sponsor, with sponsor class industry, and Eli Lilly and Company as a collaborator. The openFDA record for NDA204629 names BOEHRINGER INGELHEIM as the application sponsor.
Roles
- Company
- Funder
Sector
Industry
Record details
- Record id
cardio:boehringer-ingelheim- Content hash
b96fe78733ab8c02d3c996b351a6f3a830eee8d8c0d050a75c96ff4406d4cf71